LigaChem Biosciences
LigaChem Biosciences has 1 licensing announcement in this dataset, dated 2023-12-26.
- Country / operating region
- South Korea
- Ticker
- 141080.KQ
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- www.ligachembio.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| LCB84 | Trop2 | ADC | Phase 1/2 | 2023-12-26 |
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| LCB84 | Phase 1/2 (at announcement) | — | 查無 | 查無 | 2023-12-26 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2023-12-26 | Janssen Biotech, Inc. | LCB84 | USD 100m | 查無 | 查無 | ≤ USD 1700m | Option exercise payment USD 200m Separate option exercise payment; Janssen takes sole development responsibility after option exercise. |
| Counterparty | Territory | Royalties |
|---|---|---|
| Janssen Biotech, Inc. | Worldwide | Tiered royalties on net sales. |
Asia ADC assets and licensing deals
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無